Clazosentan Sodium |
Ro-61-1790; ACT-108475; AXV-034; VML-588; AXV-034343 |
Approved |
F. Hoffmann-La Roche Ltd |
Pivlaz |
Japan |
Subarachnoid Hemorrhage; Vasospasm, Intracranial; Cerebral Infarction; Brain Ischemia |
Idorsia Pharmaceuticals Ltd |
2022-01-20 |
Brain Ischemia; Aneurysm; Vasospasm, Intracranial; Subarachnoid Hemorrhage; Cerebral Infarction |
Details
|
Macitentan/Tadalafil |
|
Approved |
Actelion Pharmaceuticals Ltd |
OPSYNVI |
United States |
Pulmonary Arterial Hypertension |
Actelion Pharmaceuticals Us Inc |
2024-03-22 |
Pulmonary Arterial Hypertension |
Details
|
Ambrisentan |
LU-208075; BSF-208075; GSK-132576A |
Approved |
Abbott Laboratories |
Letairis, Volibris, 凡瑞克 |
United States |
Pulmonary Arterial Hypertension |
Gilead Sciences Inc |
2007-06-15 |
Acute Kidney Injury; Anemia, Sickle Cell; Hepatorenal Syndrome; Vascular Diseases; Pulmonary Arterial Hypertension; Thromboembolism; Hypertension; Hypoxia; Ascites; Hypertension, Pulmonary; Sarcoidosis; Scleroderma, Systemic; Hypertension, Portal; Idiopathic Pulmonary Fibrosis; Fibrosis; Coronavirus Disease 2019 (COVID-19); Liver Cirrhosis |
Details
|
Sparsentan |
RE-021; PS-433540; BMS-346567 |
Approved |
Bristol-Myers Squibb Company |
Filspari |
United States |
Glomerulonephritis, IGA |
Travere Therapeutics Inc |
2023-02-17 |
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Glomerulonephritis, IGA; Kidney Diseases; Vasculitis; Autoimmune Diseases; Nephrosis, Lipoid; Hypertension; Immune System Diseases; Glomerulosclerosis, Focal Segmental; Cardiovascular Diseases; Nephritis, Hereditary; Glomerulonephritis |
Details
|
Bosentan Hydrate |
ACT-050088; HGP-1206; Ro-47-0203; Ro-47-0203/029; Ro-47-0203/039 |
Approved |
F. Hoffmann-La Roche Ltd |
Stayveer, 全可利, Tracleer |
United States |
Pulmonary Arterial Hypertension |
Actelion Pharmaceuticals Ltd |
2001-11-20 |
Pulmonary Fibrosis; Heart Defects, Congenital; Diabetes Mellitus; Anemia, Sickle Cell; Persistent Fetal Circulation Syndrome; Ulcer; Sleep Apnea Syndromes; Glaucoma; Pulmonary Arterial Hypertension; Hypertension; Hepatopulmonary Syndrome; Hypertension, Pulmonary; Lung Diseases, Interstitial; Sarcoidosis; Liver Cirrhosis; Chronic thromboembolic pulmonary hypertension; Fibrosis; Scleroderma, Systemic; Idiopathic Pulmonary Fibrosis; Diabetes Mellitus, Type 2; Heart Septal Defects, Atrial |
Details
|
Macitentan |
ACT-064992; Actelion-1; JNJ-67896062 |
Approved |
Actelion Pharmaceuticals Ltd |
Zependo, Opsumit, 傲朴舒 |
United States |
Pulmonary Arterial Hypertension |
Actelion Pharmaceuticals Us Inc |
2013-10-18 |
Hypertension, Pulmonary; Pulmonary Embolism; Heart Failure; Idiopathic Pulmonary Fibrosis; Scleroderma, Systemic; Chronic thromboembolic pulmonary hypertension; Glioblastoma; Lung Diseases, Interstitial; Thromboembolism; Pulmonary Arterial Hypertension; Eisenmenger Complex; Ulcer; Anemia, Sickle Cell; Chronic Disease; Heart Defects, Congenital |
Details
|
Aprocitentan |
ACT-132577; AC-080; JNJ-2820 |
Approved |
Idorsia Pharmaceuticals Ltd, Actelion Pharmaceuticals Ltd |
TRYVIO |
United States |
Hypertension |
Idorsia Pharmaceuticals Ltd |
2024-03-19 |
Hypertension; Hepatic Insufficiency; Essential Hypertension; Renal Insufficiency, Chronic |
Details
|